2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Tachycardia, Supraventricular
1
Heart Failure
1
Cardiotoxicity
1
Atrial Fibrillation
1
Arrhythmias, Cardiac
1
Interventions
Cyclophosphamide
1499
Cisplatin
1434
Paclitaxel
1339
Radiotherapy
1310
Carboplatin
1266
Gemcitabine
1226
Docetaxel
1133
Bevacizumab
1070
Fluorouracil
906
Doxorubicin
805
Dexamethasone
755
Rituximab
744
Capecitabine
735
Oxaliplatin
709
pembrolizumab
697
Etoposide
679
Irinotecan
639
Filgrastim
624
Cytarabine
587
Nivolumab
586
Leucovorin
583
Vincristine
517
Cetuximab
479
Prednisone
478
Bortezomib
474
Trastuzumab
468
Erlotinib Hydrochloride
467
Surveys and Questionnaires
460
Methotrexate
444
Lenalidomide
436
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gonadal Steroid Hormones
×
Clear all
NCT03243604
2018-10-18
ARBITRAGE
Groupe Hospitalier Pitie-Salpetriere
Completed
1,717 enrolled